GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

SynAct Pharma SYNACT.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

15.28

0.00%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in SEK, from our data supplier.

FY2025

Net income

−SEK 110.8m

FY2016FY2025

Free cash flow

−SEK 97.3m

FY2016FY2025

Shareholders' equity

SEK 170.3m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross profit—−SEK 617,000−SEK 778,000−SEK 1.1m−SEK 88,000—−SEK 338,514−SEK 303,567−SEK 252,019−SEK 190,362
Research and developmentSEK 85.6mSEK 49.3mSEK 105.1mSEK 70.1mSEK 60.5mSEK 22.8mSEK 15,174SEK 21.8m——
Operating income−SEK 117.2m−SEK 90.0m−SEK 224.5m−SEK 106.8m−SEK 76.7m−SEK 31.3m−SEK 24.7m−SEK 28.4m−SEK 18.2m−SEK 17.0m
Net income−SEK 110.8m−SEK 82.4m−SEK 215.8m−SEK 99.2m−SEK 69.3m−SEK 26.6m−SEK 24.0m−SEK 23.4m−SEK 15.4m−SEK 15.5m
Diluted earnings per share-2.08-1.97-6.15-3.47-2.65-1.04-1.23-1.59-1.18-1.20

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 220.5mSEK 270.5mSEK 228.0mSEK 142.6mSEK 38.4mSEK 21.6mSEK 23.8mSEK 14.0mSEK 15.2mSEK 30.6m
Cash and short-term investmentsSEK 53.4mSEK 61.2mSEK 62.4mSEK 108.2mSEK 24.0mSEK 14.5mSEK 3.6mSEK 7.1mSEK 10.2mSEK 26.6m
Total liabilitiesSEK 50.2mSEK 56.4mSEK 51.8mSEK 16.1mSEK 17.5mSEK 5.7mSEK 10.3mSEK 3.7mSEK 2.3mSEK 3.5m
DebtSEK 1.8mSEK 1.9mSEK 637,000SEK 2.1mSEK 3.1m—————
Shareholders' equitySEK 170.3mSEK 214.2mSEK 176.2mSEK 126.5mSEK 20.9mSEK 15.9mSEK 13.5mSEK 10.3mSEK 12.9mSEK 27.1m
Shares outstanding53m42m35m29m26m25m19m15m13m13m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 97.3m−SEK 89.2m−SEK 100.2m−SEK 117.6m−SEK 65.0m−SEK 33.2m−SEK 16.1m−SEK 24.2m−SEK 17.2m−SEK 14.7m
Capital spending—————−SEK 33.2m−SEK 498,998—−SEK 264,496−SEK 902,963
Free cash flow−SEK 97.3m−SEK 89.2m−SEK 100.2m−SEK 117.6m−SEK 65.0m−SEK 66.5m−SEK 16.6m−SEK 24.2m−SEK 17.5m−SEK 15.6m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Operating income−SEK 24.6m−SEK 30.6m−SEK 22.8m−SEK 35.9m−SEK 30.3m−SEK 28.1m−SEK 20.8m−SEK 24.3m
Net income−SEK 22.0m−SEK 25.5m−SEK 22.9m−SEK 35.7m−SEK 27.5m−SEK 24.7m−SEK 18.4m−SEK 20.5m
Diluted earnings per share-0.39-0.45-0.43-0.67-0.52-0.46-0.44-0.49
Cash from operations−SEK 34.0m−SEK 32.0m−SEK 23.0m−SEK 25.0m——−SEK 17.0m−SEK 24.0m
Capital spending−SEK 34.0m———————
Free cash flow−SEK 68.0m———————
Total assetsSEK 208.2mSEK 237.9mSEK 220.5mSEK 253.6mSEK 243.6mSEK 219.2mSEK 270.5mSEK 217.1m
Cash and short-term investmentsSEK 14.2mSEK 65.8mSEK 53.4mSEK 77.9mSEK 68.9mSEK 51.2mSEK 61.2mSEK 38.5m
DebtSEK 656,000SEK 636,000SEK 616,000SEK 615,000SEK 605,000SEK 577,000SEK 595,000SEK 498,000
Shareholders' equitySEK 171.7mSEK 193.7mSEK 170.3mSEK 194.8mSEK 196.4mSEK 181.1mSEK 214.2mSEK 169.2m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income3.1%30.2%73.5%
Net income3.8%33.1%60.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-10.8-4.5-1.4-7.7-17.4-13.8-2.1-1.3-1.5-0.8

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.